Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 03/31/15
Due: 03/31/16
Phase: N/A
Priority: Normal
Start: 02/28/19
End: 12/22/24
Due: 12/22/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | NCT01042704 | Robert Redner, MD | user2@example.com | None | 2008-02-29 | 2015-03-31 | 2016-03-31 | - | - | 2025-07-14 |
| Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy | NCT03839446 | Robert Redner, MD | user2@example.com | None | 2019-02-28 | 2024-12-22 | 2025-12-22 | - | - | 2025-07-14 |